Mercado de antibióticos: mapeo competitivo y perspectivas estratégicas 2031

  • Report Code : TIPRE00003406
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 161
Buy Now

El mercado de antibióticos fue valorado en 44.111,31 millones de dólares en 2020 y se prevé que alcance los 59.253,24 millones de dólares en 2028; se espera que crezca a una tasa compuesta anual del 4,0 % durante 2021-2028.

Los antibióticos son medicamentos potentes que se utilizan para luchar contra infecciones y enfermedades bacterianas. Estos se usan específicamente para tratar infecciones causadas por bacterias como Staph., Strep. o E. coli. Los antibióticos matan las bacterias (bactericidas) o impiden que se reproduzcan y crezcan (bacteriostáticos). El mercado de antibióticos no actúa contra ninguna infección viral. Algunas de las infecciones comunes tratadas con antibióticos son, conjuntivitis, infección de la piel o tejidos blandos, infección del tracto respiratorio superior, bronquitis, faringitis estreptocócica (faringitis estreptocócica), y entre otras.

Lucrativos Mercados Regionales de Antibióticos


Perspectivas del mercado

Creciente desarrollo de medicamentos genéricos

Un medicamento genérico es una copia de un medicamento de marca que ya no existe. Ya no está bajo patente. Las versiones genéricas se introducen en el mercado con el objetivo de ofrecer medicamentos rentables y aumentar el alcance de estos medicamentos a personas pertenecientes a diferentes clases económicas. Las versiones genéricas son populares debido a su disponibilidad y asequibilidad. Por ejemplo, según un estudio publicado en el NCBI en 2018, el precio promedio de los medicamentos recetados de marca era casi 4 veces el precio promedio de los genéricos. Además, las empresas también se están centrando en el desarrollo de versiones genéricas con el objetivo de ofrecer antibióticos a costes mínimos. Por ejemplo, en junio de 2018, Lupin lanzó una solución genérica para inhalación de tobramicina en el mercado estadounidense. Además, también se prevé que el estímulo de las autoridades gubernamentales impulse la producción de antibióticos genéricos, lo que eventualmente impulsaría el crecimiento del mercado de antibióticos durante el período previsto. Por ejemplo, en febrero de 2019, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA) anunció la aprobación de la comercialización de medicamentos genéricos fabricados por compañías farmacéuticas indias en los Estados Unidos.

Información sobre el tipo de prueba

Según la clase de fármaco, el mercado de antibióticos se segmenta en sulfonamidas, aminoglucósidos, carbapenem, macrólidos, fluoroquinolonas, penicilina, cefalosporina y otros. El segmento de cefalosporinas ocupó la mayor cuota de mercado en 2020; mientras que se prevé que el segmento de fluoroquinolonas registre la CAGR más alta del mercado durante el período de pronóstico.

Mercado global de antibióticos, por tipo de producto: 2020 y 2020 2028


Información sobre el mecanismo de acción

Basado en el mecanismo de acción, el mercado de antibióticos se ha segmentado en inhibidores del ácido micólico e inhibidores de la síntesis de ARN. , inhibidores de la síntesis de ADN, inhibidores de la síntesis de proteínas e inhibidores de la síntesis de la pared celular. El segmento de inhibidores de la síntesis de la pared celular tuvo la mayor participación de mercado en 2020, mientras que se estima que el segmento de inhibidores de la síntesis de ADN registrará la CAGR más alta del mercado durante el período de pronóstico.

Perspectivas estratégicas

Las empresas suelen adoptar estrategias de aprobación y lanzamiento de productos para ampliar su presencia y cartera de productos en todo el mundo y satisfacer la creciente demanda.

Los actores del mercado que operan en el mercado de antibióticos adoptan la estrategia de expansión para ampliar el número de clientes. base en todo el mundo, lo que también permite a los jugadores mantener su marca a nivel mundial. Por ejemplo, en julio de 2019, una empresa como Pfizer lanzó un consorcio de investigación internacional para descubrir y desarrollar nuevos antibióticos contra la tuberculosis en colaboración con ocho socios biotecnológicos y académicos europeos.

Mercado global de antibióticos: Por clase de fármaco

  • Cefalosporina
  • Penicilina
  • Fluoroquinolonas
  • Macrólidos
  • Carbapenem
  • Aminoglucósidos
  • Sulfonamidas
  • Otros

Mercado Global de Antibióticos – ndash; Por mecanismo de acción

  • Inhibidores de la síntesis de la pared celular
  • Inhibidores de la síntesis de proteínas
  • Inhibidores de la síntesis de ADN
  • Inhibidores de la síntesis de ARN
  • Inhibidores del ácido micólico
  • Otros

Antibióticos globales  – Por geografía

  • América del Norte
    • Estados Unidos
    • Canadá
    • México
  • < li>Europa
    • Francia
    • Alemania
    • Italia
    • Reino Unido
    • España
    • Resto de Europa
  • Asia Pacífico (APAC)
    • China
    • India
    • Corea del Sur
    • Japón
    • Australia
    • Resto de Asia Pacífico
  • Medio Oriente y África (MEA)
    • Sudáfrica
    • Arabia Saudita
    • EAU
    • Resto de Oriente Medio y África
  • América del Sur
    • Brasil
    • Argentina
    • Resto de América del Sur

Perfiles de empresas

  • Pfizer, Inc
  • Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals),
  • Abbott,
  •  GlaxoSmithKline Plc,
  • Sanofi,
  • Novartis AG,
  • Bayer AG,
  • Bristol Myers Squibb Company,
  • Eli Lilly and Company,
  • Astellas Pharma
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the regional analysis in terms of antibiotics?

The North American region holds the largest market for the breast cancer screening. The United States held the largest market for antibiotics market and is expected to grow due to factors such as increasing number of rising in prevalence of breast cancer , growing developments for screening and imaging process by the companies and others.

What are the driving factors for antibiotics market across the globe?

The growth of the market is attributed to some key driving factors such as rising prevalence of bacterial infections, growing geriatric population and increasing development of generic drugs. However, tedious and expensive process of antibiotic development is expected to restraint the growth of the market during the forecast years.

What are antibiotics ?

Antibiotics are powerful medicines that are used to fight against bacterial infections. Antibiotics are also known as antibacterials which include a range of powerful drugs and are used to treat diseases caused by bacteria. These are specifically used to treat infections caused by bacteria such as, Staph., Strep., or E. coli. and either kill the bacteria (bactericidal) or keep it from reproducing and growing (bacteriostatic). The antibiotics do not work against any viral infection. Some common infections treated with antibiotics are, conjunctivitis, skin or soft tissue infection, upper respiratory tract infection, bronchitis, streptococcal pharyngitis (strep throat) and among others.

The List of Companies - Antibiotics Market

  1. Pfizer, Inc
  2. Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals),
  3. Abbott,
  4.  GlaxoSmithKline Plc,
  5. Sanofi,
  6.  Novartis AG,
  7.  Bayer AG,
  8. Bristol Myers Squibb Company,
  9. Eli Lilly and Company,
  10. Astellas Pharma

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports